XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-based Compensation Plans (Narrative) (Details)
$ / shares in Units, $ in Millions
3 Months Ended
Nov. 30, 2021
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Share-based Payment Arrangement, Expense | $   $ 2.6 $ 2.5
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $   $ 14.5  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   277,344 258,522
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 1.70%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0.76%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 2 years 9 months 29 days    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 1.70%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0.76%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 2 years 9 months 29 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares   141,135  
Phantom Share Units (PSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value | $ / shares   $ 14.40  
Share-based compensation liability | $   $ 1.9  
Granted, shares   199,549  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 13.64  
Granted, shares   199,549  
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period   240,412  
Share-based compensation, units awarded but not yet granted   57,627  
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period   130,018  
Granted, shares   135,129  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 13.64  
Granted, shares   135,129  
Market Based Performance Shares      
Granted, shares   230,089  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 15.76  
Granted, shares   230,089  
Equity Option      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   1.62%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   1.33%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term   6 years  
Granted, shares   457,482  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   1.62%  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 3.43  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   1.33%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term   6 years  
Granted, shares   457,482  
Minimum [Member] | Performance Shares [Member]      
Performance Factors   0  
Minimum [Member] | Market Based Performance Shares      
Performance Factors   0  
Maximum [Member] | Performance Shares [Member]      
Performance Factors   2  
Maximum [Member] | Market Based Performance Shares      
Performance Factors   2  
Share-based Payment Arrangement, Tranche Two [Member] | Performance Shares [Member]      
Granted, shares   57,627  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 13.81  
Granted, shares   57,627